Raily Aesthetic Medicine International Holdings (HKSE:02135) EBIT: HK$3.1 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02135 Raily Aesthetic Medicine International Holdings Ltd HKSE:02135
47 GF Score
Price HK$0.12
GF Value HK$0.14
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Raily Aesthetic Medicine International Holdings EBIT?

Raily Aesthetic Medicine International Holdings HKSE:02135 +2.59% 47 EBIT is HK$3.1 Mil as of Dec. 2025. GuruFocus rates HKSE:02135 with a GF Score™ of 47/100 and a GF Value™ of HK$0.14 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Raily Aesthetic Medicine International Holdings's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was HK$10.7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$3.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Raily Aesthetic Medicine International Holdings's annualized ROC % for the quarter that ended in Dec. 2025 was 10.47%. Raily Aesthetic Medicine International Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 25.52%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Raily Aesthetic Medicine International Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.62%.

Raily Aesthetic Medicine International Holdings  (HKSE:02135) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Raily Aesthetic Medicine International Holdings's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=31.206 * ( 1 - 12.41% )/( (271.785 + 250.21)/ 2 )
=27.3333354/260.9975
=10.47 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=263.307 - 43.045 - ( 39.055 - max(0, 142.404 - 90.881+39.055))
=271.785

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=262.539 - 44.596 - ( 63.845 - max(0, 138.925 - 106.658+63.845))
=250.21

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Raily Aesthetic Medicine International Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=21.308/( ( (91.641 + max(-72.45, 0)) + (75.351 + max(-74.332, 0)) )/ 2 )
=21.308/( ( 91.641 + 75.351 )/ 2 )
=21.308/83.496
=25.52 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.783 + 9.447 + 0.16300000000001) - (43.045 + 0 + 39.798)
=-72.45

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.455 + 7.825 + 0) - (44.596 + 0 + 40.016)
=-74.332

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Raily Aesthetic Medicine International Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=3.127/55.630
=5.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raily Aesthetic Medicine International Holdings EBIT Related Terms

Raily Aesthetic Medicine International Holdings EBIT Historical Data

* Premium members only.

The historical data trend for Raily Aesthetic Medicine International Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raily Aesthetic Medicine International Holdings EBIT Chart

Raily Aesthetic Medicine International Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only -25.14 -21.55 -35.23 -66.68 3.05

Raily Aesthetic Medicine International Holdings Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.61 -0.73 -65.95 -7.53 10.65

HKSE:02135 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Raily Aesthetic Medicine International Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raily Aesthetic Medicine International Holdings EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raily Aesthetic Medicine International Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Raily Aesthetic Medicine International Holdings's EV-to-EBIT falls into.


HKSE:02135
47GF Score
Raily Aesthetic Medicine International Holdings Ltd HKSE:02135
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raily Aesthetic Medicine International Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$3.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of HK$3.1 Mil mean?
Raily Aesthetic Medicine International Holdings (HKSE:02135) has a EBIT of HK$3.1 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Raily Aesthetic Medicine International Holdings.
Is Raily Aesthetic Medicine International Holdings' EBIT too high?
Raily Aesthetic Medicine International Holdings' current EBIT is HK$3.1 Mil. Overall, Raily Aesthetic Medicine International Holdings has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raily Aesthetic Medicine International Holdings' EBIT compare to HCA and THC?
Raily Aesthetic Medicine International Holdings' EBIT of HK$3.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Raily Aesthetic Medicine International Holdings. Raily Aesthetic Medicine International Holdings's current EBIT is HK$3.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raily Aesthetic Medicine International Holdings stock overvalued right now?
Based on GuruFocus' analysis, Raily Aesthetic Medicine International Holdings (HKSE:02135) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.14, compared to a current price of HK$0.12 — trading 15% below its estimated fair value. The current EBIT is HK$3.1 Mil. Raily Aesthetic Medicine International Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Raily Aesthetic Medicine International Holdings (HKSE:02135), the current EBIT is HK$3.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raily Aesthetic Medicine International Holdings (HKSE:02135) Overvalued in 2026?

Based on GuruFocus' analysis, Raily Aesthetic Medicine International Holdings stock appears to be undervalued. The current stock price of HK$0.12 is trading 15% below its estimated GF Value™ of HK$0.14. GuruFocus considers Raily Aesthetic Medicine International Holdings to be Modestly Undervalued.

Key valuation signals for HKSE:02135:

  • EBIT: HK$3.1 Mil
  • GF Value™: HK$0.14 vs. price of HK$0.12 (15% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02135 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raily Aesthetic Medicine International Holdings Business Description

Address No. 290 North Zhongshan Road, 3-5th Floor, Minhang Tower, Gongshu District, Hangzhou, CHN
Raily Aesthetic Medicine International Holdings Ltd is an investment holding company. The company were principally engaged in the provision of aesthetic medical services, sale of aesthetic medical equipment products and provision of consulting services. The group is organized into three reportable operating segments namely Aesthetic medical services comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology service and others; Aesthetic medical equipment products comprise principally sales of collagen injection products, surgical implants and aesthetic medical skincare products; Consulting services comprise principally management consulting services of which majority of revenue comes from Aesthetic medical services.
47GF Score

Get the complete analysis for HKSE:02135

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.12
Price
HK$0.14
GF Value